参考文献

慶應義塾大学医学部学生有志：医学部生の感染予防対策

厚生労働省：新型コロナウイルス感染症について

医学部生の感染予防対策で参考としている文献一覧

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382（13）:1199-1207.

  2. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.

  3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323（11）:1061–1069.

  4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395（10223）:497-506.

  5. Pan F, Ye T, Sun P, Gui S, Liang B, Li L et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus （COVID-19） pneumonia. Radiology. 2020:200370.

  6. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20（4）:425-434.

  7. Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease （COVID-19）: a multicenter European study. Eur Arch Otorhinolaryngol. 2020.

  8. Chan J, Yuan S, Kok K, To K, Chu H, Yang J et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395（10223）:514-523.

  9. Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020;369:m1375.

  10. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 （COVID-19） outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020.

  11. Centers for Disease Control and Prevention. “People who are at higher risk for severe illness”. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fspecific-groups%2Fpeople-at-higher-risk.html, （accessed 2020-04-03）.

  12. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382（12）:1177-1179.

  13. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020:200343.

  14. Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D et al. Clinical characteristics of imported cases of coronavirus disease 2019 （COVID-19） in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. 2020.

  15. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F et al. Profiling early humoral response to diagnose novel coronavirus disease （COVID-19）. Clin Infect Dis. 2020.

  16. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020.

  17. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 （COVID-19） in China: a report of 1014 cases. Radiology. 2020:200642.

  18. Centers for Disease Control and Prevention. “Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease （COVID-19）”. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html, （accessed 2020-04-04）.

  19. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382（10）:970-971.

  20. Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. Published online February 21, 2020.

  21. Liu Y, Gayle A, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27（2）.

  22. Furushima D, Kawano S, Ohno Y, Kakehashi M. Estimation of the basic reproduction number of novel influenza A （H1N1） pdm09 in elementary schools using the SIR model. Open Nurs J. 2017;11（1）:64-72.

  23. CDC, Guidelines for Isolation Precautions, https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html

  24. Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus （2019-nCoV） or Patients Under Investigation for 2019-nCoV in Healthcare Settings. February3,2020

  25. WHO, Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations, 4/1/2020閲覧, https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations

  26. Infection Prevention and Control, Canada, Infection Prevention and Control

  27. UpToDate Coronavirus disease 2019 （COVID-19）, 4/1/2020閲覧, https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19?search=covid-19-2019-novel-coronavirus-the-basics&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

  28. Rothe C, Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany., N Engl J Med. 2020;382（10）:970. Epub 2020 Jan 30.

  29. Yu P, A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period., J Infect Dis. 2020;

  30. Wang D, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China., JAMA. 2020 Feb 7.

  31. Centers for Disease Control and Prevention, Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23 - March 16, 2020, 4/1/2020閲覧

  32. The Lancet,COVID-19: protecting health-care workers, 4/1/2020閲覧

  33. van Doremalen N, Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1., N Engl J Med. 2020;

  34. World Health Organization, Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations, 4/1/2020閲覧

  35. 毎日新聞, 4/1/2020閲覧, クラスター、病院機器介した接触感染か 大分医療センター

  36. CDC, Public Health Recommendations after Travel-Associated COVID-19 Exposure, 4/4/2020閲覧

  37. Imperial College London,Report 11 - Evidence of initial success for China exiting COVID-19 Social distancing policy after achieving containment, 4/4/2020閲覧

  38. The Lancet, From China: hope and lessons for COVID-19 control, 4/4/2020閲覧

  39. Imperial College London, Report 13 - Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries, 4/4/2020閲覧

  40. The Lancet, The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study, 4/4/2020閲覧

  41. Centers for Disease Control and Prevention. Infection Control: Severe acute respiratory syndrome coronavirus 2 （SARS-CoV-2）, February 3,2020,

  42. Kampf G, Persistence of coronoviruses on inanimate surfaces and their inactivation with biocidel agents., J Hosp INfect. 2020;

  43. Centers for Disease Control and Prevention, Cleaning and Disinfection for Households, 4/3/2020閲覧

  44. Shao F, Rational use of face masks in the COVID-19 pandemic, The Lancet

  45. Centers of Disease Control and Prevention, Use Cloth Face Coverings to Help Slow Spread | CDC, 4/4/2020閲覧

  46. Centers of Disease Control and Prevention, Detailed Disinfection Guidance. Coronavirus Disease 2019（COVID-19）, 4/3/2020閲覧

  47. 慶應義塾大学保健管理センター「新型コロナウイルス感染症について」, 4/8/2020閲覧

  48. Centers of Disease Control and Prevention, What to Do If You Are Sick. Coronavirus Disase 2019 （COVID-19）, 4/3/2020閲覧

  49. Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. Published online May 06, 2020. doi:10.1001/jama.2020.8259

  50. Wang W , Xu Y , Gao R , et al. Detection of SARS-CoV-2 in different types of clinical specimens.  JAMA. 2020. Published online March 11, 2020. doi:10.1001/jama.2020.3786

  51. Xiao AT , Gao C , Zhang S . Profile of specific antibodies to SARS-CoV-2: the first report.  J Infect. 2020;S0163-4453(20)30138-9. Published online March 21, 2020. doi:10.1016/j.jinf.2020.03.012

  52. Whitman JD, Hiatt J, Mowery C, Test performance evaluation of SARS-CoV-2 serological assays, medRxiv, https://doi.org/10.1101/2020.04.25.20074856

  53. Hadaya J, Schumm M, Livingston EH. Testing Individuals for Coronavirus Disease 2019 (COVID-19). JAMA. 2020;323(19):1981. doi:10.1001/jama.2020.5388

  54. 独立行政法人医薬品医療機器総合機構, エスプラインSARS-CoV-2（体外診断用医薬品, 製造販売承認番30200EZX00026000）, 添付文書, https://www.pmda.go.jp/PmdaSearch/ivdDetail/ResultDataSetPDF/670773_30200EZX00026000_A_01_02

  55. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.

  56. Zhou B, She J, Wang Y, Ma X. The duration of viral shedding of discharged patients with severe COVID-19. Clin Infect Dis. 2020 Apr 17;ciaa451. doi:10.1093/cid/ciaa451

  57. Anfinrud, Philip, Stadnytskyi, Valentyn, Christina E., Adriaan, Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering, 2020/04/15, New England Journal of Medicine10.1056/NEJMc2007800, https://www.nejm.org/doi/full/10.1056/NEJMc2007800

  58. Enrico Lavezzo, Suppression of COVID-19 outbreak in the municipality of Vo, Italy, medRxiv, doi: https://doi.org/10.1101/2020.04.17.20053157

  59. Kenji Mizumoto, Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020, Euro Surveill. 2020 Mar 12; 25(10): 2000180. doi: 10.2807/1560-7917.ES.2020.25.10.2000180

  60. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1, April 16, 2020, N Engl J Med 2020; 382:1564-1567 DOI: 10.1056/NEJMc2004973

  61. He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672‐675. doi:10.1038/s41591-020-0869-5

  62. Cheng H, Jian S, Liu D, et al. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Intern Med. Published online May 01, 2020. doi:10.1001/jamainternmed.2020.2020

  63. Gonzalo Bearman, Expert Guidance: Healthcare Personnel Attire in Non-Operating Room Settings, Infect Control Hosp Epidemiol. 2014 February ; 35(2): 107–121. doi:10.1086/675066.

  64. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1, April 16, 2020, N Engl J Med 2020; 382:1564-1567 DOI: 10.1056/NEJMc2004973

  65. Leung, N.H.L., Chu, D.K.W., Shiu, E.Y.C. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 26, 676–680 (2020). https://doi.org/10.1038/s41591-020-0843-2

  66. Liu, Y., Ning, Z., Chen, Y. et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature (2020). https://doi.org/10.1038/s41586-020-2271-3

  67. Indoor transmission of SARS-CoV-2 Hua Qian, Te Miao, Li LIU, Xiaohong Zheng, Danting Luo, Yuguo Li, medRxiv 2020.04.04.20053058; doi: https://doi.org/10.1101/2020.04.04.20053058